Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000439
Status:
COMPLETED
Last Update Posted:
2018-01-18
First Post:
1999-11-02
Brief Title:
Drug Treatment for Alcoholics With Bipolar Disorder
Sponsor:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Organization:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Study Overview
Official Title:
Efficacy of Valproate Maintenance in Bipolar Alcoholics
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the effectiveness of sodium valproate Depacon in treating individuals with alcohol dependence and comorbid bipolar disorder
Detailed Description:
The aim of this study is to test the mood stabilizer anticonvulsant sodium valproate in individuals with alcohol dependence and bipolar disorder in a double-blind placebo-controlled and randomized trial of 6 months duration All subjects are treated with treatment as usual which include lithium carbonate and individual dual recovery counseling and are randomized to either sodium valproate or placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None